Switzerland - Zurich SARS-CoV-2 Vaccination Cohort: Long Covid Related Outcomes of Self-reported Positive SARS-CoV-2 PCR or Rapid Antigen Test 2022

Nav

General Info

Geography

Switzerland (CHE)

Zürich

Coverage type

Subnational

Time period covered

01/2022 - 12/2022

Series or system

Switzerland - Zurich SARS-CoV-2 Cohort Study on Long Covid

Data type

Survey:

Epi surveillance
Individual
Longitudinal

Keywords

COVID-19, COVID-19 vaccines, Disease outbreaks, Fatigue, Long COVID, Mental health diagnostic interview, Mental health symptoms, Standardized assessment tools, Symptoms

Citation

Contributors

Epidemiology, Biostatistics and Prevention Institute, University of Zurich

Institute of Public Health at the University of Italy Switzerland (IPH)

Funders

Federal Office of Public Health (Switzerland)

Government of Switzerland

Swiss School of Public Health (SSPH+)

Suggested citation

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Institute of Public Health at the University of Italy Switzerland (IPH). Switzerland - Zurich SARS-CoV-2 Vaccination Cohort: Long Covid Related Outcomes of Self-reported Positive SARS-CoV-2 PCR or Rapid Antigen Test 2022.

GHDx Entry last modified on: Apr 3, 2025

Main menu

Switzerland - Zurich SARS-CoV-2 Vaccination Cohort: Long Covid Related Outcomes of Self-reported Positive SARS-CoV-2 PCR or Rapid Antigen Test 2022

Nav